These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22098276)

  • 1. Quality of bladder cancer care in the USA.
    Chamie K; Litwin MS
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):619-21. PubMed ID: 22098276
    [No Abstract]   [Full Text] [Related]  

  • 2. Follow-up of patients after curative bladder cancer treatment: guidelines vs. practice.
    Vrooman OP; Witjes JA
    Curr Opin Urol; 2010 Sep; 20(5):437-42. PubMed ID: 20657286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder-sparing procedure as good as cystectomy for treating invasive bladder cancer.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):7-9. PubMed ID: 12553324
    [No Abstract]   [Full Text] [Related]  

  • 4. ICUD-EAU International Consultation on Bladder Cancer 2012: Recommendations on bladder cancer-progress in a cancer that lacks the limelight.
    Soloway MS
    Eur Urol; 2013 Jan; 63(1):1-3. PubMed ID: 22868670
    [No Abstract]   [Full Text] [Related]  

  • 5. Urology meeting highlights prostate, bladder cancers.
    Fillon M
    J Natl Cancer Inst; 2012 Sep; 104(18):1348-9. PubMed ID: 22984200
    [No Abstract]   [Full Text] [Related]  

  • 6. Candidate quality of care indicators for localized bladder cancer.
    Cooperberg MR; Porter MP; Konety BR
    Urol Oncol; 2009; 27(4):435-42. PubMed ID: 19573775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving bladder cancer patient care: a pharmacoeconomic perspective.
    Gore JL; Gilbert SM
    Expert Rev Anticancer Ther; 2013 Jun; 13(6):661-8. PubMed ID: 23773101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the association between delay in diagnosis and decreased survival in bladder cancer.
    Porter MP
    Cancer; 2010 Nov; 116(22):5122-5. PubMed ID: 20665888
    [No Abstract]   [Full Text] [Related]  

  • 9. Earlier use of aggressive therapy could prevent one-third of bladder cancer deaths.
    Pinkowish MD
    CA Cancer J Clin; 2009; 59(3):142-4. PubMed ID: 19369683
    [No Abstract]   [Full Text] [Related]  

  • 10. Delays in diagnosis and bladder cancer mortality.
    Hollenbeck BK; Dunn RL; Ye Z; Hollingsworth JM; Skolarus TA; Kim SP; Montie JE; Lee CT; Wood DP; Miller DC
    Cancer; 2010 Nov; 116(22):5235-42. PubMed ID: 20665490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High morbidity and mortality found for high-risk, non-muscle-invasive bladder cancer.
    Barton MK
    CA Cancer J Clin; 2013; 63(6):371-2. PubMed ID: 24122724
    [No Abstract]   [Full Text] [Related]  

  • 12. Variations in treatment policies and outcome for bladder cancer in the Netherlands.
    Goossens-Laan CA; Visser O; Wouters MW; Jansen-Landheer ML; Coebergh JW; van de Velde CJ; Hulshof MC; Kil PJ
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S100-7. PubMed ID: 20598491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rationale for developing benchmarks for the treatment of muscle-invasive bladder cancer.
    Lee CT
    Urol Oncol; 2007; 25(1):57-65. PubMed ID: 17208141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [S3 guideline for bladder cancer : Claim and reality - a critical commentary from the guideline coordinators].
    Retz M; Maisch P; Gschwend JE
    Urologe A; 2016 Sep; 55(9):1188-91. PubMed ID: 27581238
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of questionable quality care in nonmuscle invasive bladder cancer.
    Gore JL; Porter MP
    Cancer; 2010 Jun; 116(11):2508-10. PubMed ID: 20336786
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recommendations for the diagnosis, treatment, and follow-up of cancer of the bladder].
    Lobel B; Abbou CC; Brausi MA; Flanigan RC; Kameyama S; Scher HI; Caffrey JM; Tachibana M
    Prog Urol; 1998 Sep; 8(4):590-2. PubMed ID: 9834529
    [No Abstract]   [Full Text] [Related]  

  • 17. Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a survey.
    Witjes JA; Melissen DO; Kiemeney LA
    Eur Urol; 2006 Mar; 49(3):478-84. PubMed ID: 16406242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations.
    Witjes JA; Redorta JP; Jacqmin D; Sofras F; Malmström PU; Riedl C; Jocham D; Conti G; Montorsi F; Arentsen HC; Zaak D; Mostafid AH; Babjuk M
    Eur Urol; 2010 Apr; 57(4):607-14. PubMed ID: 20116164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of elderly patients with urothelial carcinoma of the bladder: guideline concordance and predictors of overall survival.
    Bolenz C; Ho R; Nuss GR; Ortiz N; Raj GV; Sagalowsky AI; Lotan Y
    BJU Int; 2010 Nov; 106(9):1324-9. PubMed ID: 20500510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.